Wise and NYU Langone Health Publish the Results of Personal Zen App for Multiple Sclerosis in Frontiers in Neurology
Shots:
- The clinical study evaluates Wise’s Personal Zen app in 35 patients with MS. The company is developing PTD with adaptive- personalized gameplay to address mental health needs in targeted populations like MS
- The results demonstrated that Personal Zen app offers ABMT approach to reduce anxiety by 38.3% in adults and 20.1% in teenagers. Additionally- it showed 14.5% reduction in broad negative mood as measured by PANAS
- The company is also studying the effects of its gamified ABMT on other patient populations to reduce anxiety in pregnant women and patients with alcohol use disorder
| Ref: PR Newswire | Image: PR Newswire
Click here to read the full press release
Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at [email protected].
